Cigna faces a surprising shakeup as its oncology leader, Jeffrey Langsam, joins The Oncology Institute as Chief Clinical ...

CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter 2025 results. Despite concerns over the company’s decision to implement ...

Davis Selected Advisers’ 13F portfolio value increased to $17.35B, with the number of holdings rising from 100 to 104. Learn ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an ...

UnitedHealth Group announced the immediate resignation of CEO Andrew Witty for personal reasons on Tuesday and withdrew its already-slashed full-year earnings outlook, citing a continued acceleration ...

Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) ...

UnitedHealth remains in fine financial shape. As of December 2024, the company owed $77 billion in debt (held at the parent level), or gross debt/EBITDA of around 2 times. The parent company typically ...

Cigna’s stock slipped over 5% on a day the S&P 500 soared, thanks to a bold move by President Trump targeting pharmacy ...

President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.